“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about ACELYRIN, INC
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
ACELYRIN, INC. (Nasdaq: SLRN) is a Los Angeles area-based late-stage clinical biopharma company with additional operations in the San Francisco Bay area focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising product candidates. ACELYRIN is embedding a corporate culture of Courageous CaringTM -- placing patients first and embracing the concept that all of us are better than any one of us -- as we seek to addresses the most basic human needs: to live a productive life free from diseases
| C-Level 4 | VP - Level11 |
| Director49 | Manager16 |
| Others47 | |
| Structure | Email Format |
|---|---|
| <first>.<last>@ | John.Smith@acelyrin.com |
| <first>.<l>@ |
John. |
| Pain Points | Locations | Technologies |
|---|---|---|
| Build & Release | Agoura Hills, CA | communication, e, test methods, risk, cgmp, compliance, assessment, change control, collaboration, usability, troubleshooting, packaging, operations, infrastructure, gmp |
| Build & Release | California, United States | presence, communication, database, data communication, forecasting, e, j, data dissemination, data management, collaboration, workflow |
| Build & Release | South San Francisco, CA | quality assurance, communication, e, risk, operating procedures, compliance, assessment, data management, collaboration, operations, infrastructure |
| Compliance | Agoura Hills, CA | communication, e, test methods, risk, cgmp, compliance, assessment, change control, collaboration, usability, troubleshooting, packaging, operations, infrastructure, gmp |
| Compliance | California, United States | presence, communication, database, data communication, forecasting, e, j, data dissemination, data management, collaboration, workflow |
ACELYRIN, INC looking to hire in Build & Release in Agoura Hills, CA
ACELYRIN, INC looking to hire in Compliance in Agoura Hills, CA
ACELYRIN, INC looking to hire in Content Writing in California, United States
Gcp
Netsuite
Board
Director
Excel
Archival
Assessment
Audit
Bi
Cgmp
At ACELYRIN, INC. the patient is at the center of our culture and our business. We are guided by ...
View MoreAt ACELYRIN, INC. the patient is at the center of our culture and our business. We are guided by ...
View MoreAt ACELYRIN, INC the patient is at the center of our culture and our business. We are guided by o...
View MoreAt ACELYRIN, INC. the patient is at the center of our culture and our business. We are guided by ...
View MoreAt ACELYRIN, INC the patient is at the center of our culture and our business. We are guided by o...
View MoreAt ACELYRIN, INC the patient is at the center of our culture and our business. We are guided by o...
View MoreAt ACELYRIN, INC. the patient is at the center of our culture and our business. We are guided by ...
View MoreAt ACELYRIN, the patient is at the center of our culture and our business. We are guided by our v...
View MoreAlumis said Wednesday that it has completed its merger with Acelyrin . Each Acelyrin shareholder will receive 0.4814 Alumis share for each Acelyrin share
Read MoreStrategic biotech merger strengthens pipeline of immune disease therapies with extended cash runway to 2027. Key details of the stock-for-stock transaction
Read MoreStockholders back strategic merger to strengthen immune disease research. Combined entity promises enhanced drug development capabilities.
Read MoreStockholders back merger creating specialized immunology biopharma. 0.4814 Alumis shares per ACELYRIN share in Q2 2025 deal. See growth potential.
Read MoreACELYRIN, INC. (Nasdaq: SLRN) is a Los Angeles area-based late-stage clinical biopharma company with additional operations in the San Francisco Bay area focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising product candidates. ACELYRIN is embedding a corporate culture of Courageous CaringTM -- placing patients first and embracing the concept that all of us are better than any one of us -- as we seek to addresses the most basic human needs: to live a productive life free from diseases
Acelyrin, inc operates in the Biotechnology research industry.
Acelyrin, inc's revenue is $5.50m
Acelyrin, inc has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.